Cochrane Clinical Answers
(FIVE YEARS 2248)
(FIVE YEARS 0)
Published By Wiley (John Wiley & Sons)
Updated Wednesday, 16 June 2021
For adults with systemic lupus erythematosus (SLE) and cutaneous disease, what are the effects of intravenous (IV)/subcutaneous (SC) monoclonal antibodies?